Gazella Biotech
PrivateLast Round
Grant
Dec 4, 2025
Total Funding Raised
$1.19M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gazella Biotech operates in Healthcare & Life Sciences and is based in Spain. Its latest recorded funding round was a Grant round in December 2025.
Gazella Biotech is a biotechnology company that develops advanced therapies for the treatment of metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gazella Biotech Comparables
Compare Gazella Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Courage Therapeutics | 81% | |
| Biolexis Therapeutics, Inc. | 77% | |
| Saniona AB | 70% |
For institutional investors. Book with your work email.
Gazella Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 4, 2025 | ||||
| Seed | Apr 1, 2024 |
For institutional investors. Book with your work email.
Gazella Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agencia Estatal de Investigación | Grant |
| Nowture | Seed |
| Unirisco Galicia | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 79% MoM to 1.7K.
- Dec 4, 2025
$1.13M grant received from Agencia Estatal de Investigación.
For institutional investors. Book with your work email.
Gazella Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gazella Biotech's valuation, stock price, and market status.
Is Gazella Biotech a public or private company?
Gazella Biotech is a private company.
What is the current stock price of Gazella Biotech?
Gazella Biotech is a private company, so its shares have no public market price. Caplight tracks Gazella Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gazella Biotech worth (valuation)?
Valuation information for Gazella Biotech is not publicly available.
Can I buy Gazella Biotech stock?
Gazella Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gazella Biotech's last funding round?
Gazella Biotech's most recent funding round was Grant on December 4, 2025.
Who are the main investors in Gazella Biotech?
Key investors in Gazella Biotech include Agencia Estatal de Investigación, Nowture, Unirisco Galicia.
Will Gazella Biotech IPO soon?
No public IPO plans have been announced for Gazella Biotech.
How can I track Gazella Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Gazella Biotech's shares on secondary markets.